[
  {
    "ts": "2025-11-27T11:31:00+00:00",
    "headline": "Where Will Vertex Pharmaceuticals Be in 5 Years",
    "summary": "Prediction: Vertex will be much larger by the end of the decade.",
    "url": "https://www.fool.com/investing/2025/11/27/where-will-vertex-pharmaceuticals-be-in-5-years/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "8f882226-8eba-35e9-91da-6da5ff3073ab",
      "content": {
        "id": "8f882226-8eba-35e9-91da-6da5ff3073ab",
        "contentType": "STORY",
        "title": "Where Will Vertex Pharmaceuticals Be in 5 Years",
        "description": "",
        "summary": "Prediction: Vertex will be much larger by the end of the decade.",
        "pubDate": "2025-11-27T11:31:00Z",
        "displayTime": "2025-11-27T11:31:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/c876c911e5e4dde6014e8897585618c8",
          "originalWidth": 978,
          "originalHeight": 668,
          "caption": "A Vertex Pharmaceuticals employee working in a manufacturing plant with another employee looking on.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hrCGxSFEpqKoRJNJcfj4vA--~B/aD02Njg7dz05Nzg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/c876c911e5e4dde6014e8897585618c8.cf.webp",
              "width": 978,
              "height": 668,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NxlQW61QRdpHgKumAxX77w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/c876c911e5e4dde6014e8897585618c8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/27/where-will-vertex-pharmaceuticals-be-in-5-years/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/where-vertex-pharmaceuticals-5-years-113100264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-27T16:12:37+00:00",
    "headline": "Is Vertex Still a Bargain After Latest Pipeline Progress and Five Year 90.6% Gain?",
    "summary": "If you have ever wondered whether Vertex Pharmaceuticals is a bargain right now, you are not alone. Let's break down whether the current price really stacks up to the company's fundamentals. Despite some volatility over the past year with a -7.0% return, Vertex has still delivered a solid 90.6% gain for investors over the last five years and is currently up 6.5% in 2024. Recently, Vertex Pharmaceuticals has grabbed attention with new product launches, advances in its pipeline, and positive...",
    "url": "https://finance.yahoo.com/news/vertex-still-bargain-latest-pipeline-161237166.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "d66fc14a-5419-322e-9ee9-d031502927c7",
      "content": {
        "id": "d66fc14a-5419-322e-9ee9-d031502927c7",
        "contentType": "STORY",
        "title": "Is Vertex Still a Bargain After Latest Pipeline Progress and Five Year 90.6% Gain?",
        "description": "",
        "summary": "If you have ever wondered whether Vertex Pharmaceuticals is a bargain right now, you are not alone. Let's break down whether the current price really stacks up to the company's fundamentals. Despite some volatility over the past year with a -7.0% return, Vertex has still delivered a solid 90.6% gain for investors over the last five years and is currently up 6.5% in 2024. Recently, Vertex Pharmaceuticals has grabbed attention with new product launches, advances in its pipeline, and positive...",
        "pubDate": "2025-11-27T16:12:37Z",
        "displayTime": "2025-11-27T16:12:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ihFoSuY9PLXURl2kI_sV.w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bIz6sh0rX4c7ACsVP8z51w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-still-bargain-latest-pipeline-161237166.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-still-bargain-latest-pipeline-161237166.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-27T23:45:27+00:00",
    "headline": "Vertex (VRTX) Q3 2025 Earnings Call Transcript",
    "summary": "Vertex delivered strong performance across the board in Q3 with $3.08 billion in revenue, reflecting double-digit growth versus Q3 2024.  As we continue to extend our leadership in CF, we're also diversifying our revenue base by product and by geography with the growing global momentum of CASGEVY and the broad uptake JOURNAVX and acute pain across a wide range of prescribers pain types and settings of care, Concurrently, we are forward planning for the fourth vertical of Vertex's growth.  Two, bring forward a medicine that restores CFTR function to normal levels as measured by sweat chloride and to do so from as early in life as possible.",
    "url": "https://www.fool.com/earnings/call-transcripts/2025/11/27/vertex-vrtx-q3-2025-earnings-call-transcript/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "c78e0f33-2f8c-3c7d-9261-7bbe3f86e3b8",
      "content": {
        "id": "c78e0f33-2f8c-3c7d-9261-7bbe3f86e3b8",
        "contentType": "STORY",
        "title": "Vertex (VRTX) Q3 2025 Earnings Call Transcript",
        "description": "",
        "summary": "Vertex delivered strong performance across the board in Q3 with $3.08 billion in revenue, reflecting double-digit growth versus Q3 2024.  As we continue to extend our leadership in CF, we're also diversifying our revenue base by product and by geography with the growing global momentum of CASGEVY and the broad uptake JOURNAVX and acute pain across a wide range of prescribers pain types and settings of care, Concurrently, we are forward planning for the fourth vertical of Vertex's growth.  Two, bring forward a medicine that restores CFTR function to normal levels as measured by sweat chloride and to do so from as early in life as possible.",
        "pubDate": "2025-11-27T23:45:27Z",
        "displayTime": "2025-11-27T23:45:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73",
          "originalWidth": 400,
          "originalHeight": 427,
          "caption": "Logo of jester cap with thought bubble.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V1aMxfEJkXDsPjicitZiIw--~B/aD00Mjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 400,
              "height": 427,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XzH.opsl71yJif6AsJGwPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/earnings/call-transcripts/2025/11/27/vertex-vrtx-q3-2025-earnings-call-transcript/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-vrtx-q3-2025-earnings-234527347.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]